ESPEROVAX
LIVE

Serial Number

98324183

Owner

Esperovax, Inc.

Attorney

J. Matthew Buchanan

Filing Date

Dec 20, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ESPEROVAX Trademark

Serial Number: 98324183

ESPEROVAX is a trademark filed by Esperovax, Inc. on December 20, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Esperovax, Inc. (10 trademarks)

46701 Commerce Center Dr.
Plymouth, MI 48170

Entity Type: 03

Trademark Details

Filing Date

December 20, 2023

Registration Date

Not Registered

Published for Opposition

November 26, 2024

Goods & Services

Medical research in the field of vaccines and medicines; Research and development of vaccines and medicines; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of vaccines and medicines; Pharmaceutical research and development; Research and development in the field of immunology; Research and development in the field of microorganisms, namely, research and development related to yeast; Research and development in the field of therapeutics; Development of pharmaceutical preparations and medicines; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products; Medical and scientific research; Research and development of pharmaceutical and therapeutic preparations; Pharmaceutical, biologic, and vaccine research and development

Vaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jul 6, 2026 EX3G
SOU EXTENSION 3 FILED
Jul 6, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 6, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 7, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jan 6, 2026 EX2G
SOU EXTENSION 2 FILED
Jan 6, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 6, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 30, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 30, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 28, 2025 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Aug 11, 2025 TPEX
NOTICE OF REVIVAL - E-MAILED
Aug 11, 2025 NREV
PETITION TO REVIVE-GRANTED
Aug 11, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 11, 2025 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 11, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 11, 2025 ABN6
SOU EXTENSION 1 FILED
Jul 6, 2025 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 30, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 30, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 30, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 30, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 23, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 23, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 23, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2024 NWOS
NEW APPLICATION ENTERED
Dec 20, 2023 NWAP